EDAP TMS S.A. Stock (NASDAQ:FOCL)


RevenueFinancialsChartTranscripts

Previous Close

$5.42

52W Range

$1.21 - $5.64

50D Avg

$4.44

200D Avg

$3.52

Market Cap

$206.71M

Avg Vol (3M)

$38.10K

Beta

-0.03

Div Yield

-

FOCL Company Profile


EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

FR

Employees

289

IPO Date

Aug 01, 1997

Website

FOCL Performance


FOCL Financial Summary


Dec 25Dec 24Dec 23
Revenue$70.75M$69.35M$65.32M
Operating Income$-25.21M$-22.95M$-22.10M
Net Income$-29.34M$-20.57M$-22.90M
EBITDA$-25.05M$-17.70M$-20.31M
Basic EPS$-0.78$-0.55$-0.62
Diluted EPS$-0.78$-0.55$-0.62

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 07, 26 | 11:00 AM
Q4 25Mar 25, 26 | 8:30 AM
Q3 25Nov 06, 25 | 8:30 AM